UNSPSC 51273906: Atropine/neostigmine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CN205. This VA Drug Class (CN205) classifies this compound as belonging to the group ANESTHETIC ADJUNCTS.

UNSPSC 51273906 Atropine/neostigmine is a Commodity code that, in current state and local procurement activity, captures demand for pharmaceutical products including naloxone, generic multi-source drugs, and over-the-counter medicines procured through competitive bidding and cooperative purchasing vehicles. State and local health departments, county health services, and state HHS agencies are the primary issuing bodies, often sourcing through established wholesaler networks and seeking compliance with cGMP standards, FDA requirements, and supply chain security regulations. Vendors bidding under this code must typically maintain direct contractual relationships with authorized pharmaceutical wholesalers, carry substantial insurance coverage (commercial general liability often $5 million or higher), and demonstrate pricing flexibility across multiple formats including flat pricing and net price structures. Procurement typically requires quarterly or regular deliveries to specified health facilities, electronic submission through e-procurement portals, and adherence to federal regulations when FEMA or HHS funding is involved.

Recent activity spans Florida, Texas, and Minnesota. Seminole County, Florida issued IFB 60459723LAS in June 2026 (due July 26, 2023) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through quarterly deliveries to its Community Health Building. The Texas Health and Human Services Commission posted RFI HHS0017013 in April 2026 to gather vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, signaling future formal procurement activity for direct pharmacy contracting outside traditional PBM and GPO channels. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by Minnesota's Department of Administration, issued RFP S1070000015802 in January 2026 (due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed through AmerisourceBergen, Cardinal Health, and Morris & Dickson, with pricing weighted at 75 percent of evaluation and awards effective July 1, 2026. MMCAP's multi-state cooperative structure extends participation to Oregon and other member jurisdictions, indicating consolidated purchasing leverage and recurring contract cycles.